1. Summary Information

		Country	India
Company Name	AUCTUS PHARMA LIMITED	Principal Name 1	Mr. Aluru Sivarama Prasad
Status	Satisfactory	Principal Name 2	Mr. Suryadevara Venkateshwara Rao
		Registration #	01 – 34319
Street Address	Flat No.102, 1^st Floor, Aditya Trade Centre, Ameerpet, Hyderabad – 500 038, Andhra Pradesh, India
Established Date	25.04.2000	SIC Code	--
Telephone#	91-40-66361958 / 59	Business Style 1	Manufacturer
Fax #	91-40-23757626	Business Style 2	--
Homepage	http://www.auctuspharma.com	Product Name 1	Active Pharmaceutical Ingredients
# of employees	--	Product Name 2	Drug Intermediates
Paid up capital	Rs.39,000,000/-	Product Name 3	--
Shareholders	Foreign holdings 2.56%, Directors or relatives of directors 91.85%, Other top fifty shareholders 5.59%	Banking	Indian Overseas Bank
Public Limited Corp.	No	Business Period	13 Years
IPO	No	International Ins.	-
Public Enterprise	No	Rating	Ba (43)
Related Company
Relation	Country --	Company Name	CEO
--	--	--	--
Note	-

2. Summary Financial Statement

Balance Sheet as of	31.03.2012		(Unit: Indian Rs.)
Assets		Liabilities
Current Assets	327,012,000	Current Liabilities	286,958,000
Inventories	121,291,000	Long-term Liabilities	220,049,000
Fixed Assets	350,387,000	Other Liabilities	29,630,000
Deferred Assets	0,000	Total Liabilities	536,637,000
Invest& other Assets	0,000	Retained Earnings	223,053,000
		Net Worth	262,053,000
Total Assets	798,690,000	Total Liab. & Equity	798,690,000
Total Assets (Previous Year)	746,008,000
P/L Statement as of	31.03.2012		(Unit: Indian Rs.)
Sales	963,051,000	Net Profit	33,877,000
Sales(Previous yr)	945,117,000	Net Profit(Prev.yr)	37,706,000

MIRA INFORM REPORT

Report Date :

01.06.2013

IDENTIFICATION DETAILS

Name :	AUCTUS PHARMA LIMITED [w.e.f. 30.07.2007]
Formerly Known As :	AUCTUS PHARMA PRIVATE LIMITED [w.e.f. 20.08.2003] SHARP ORGANICS PRIVATE LIMITED
Registered Office :	Flat No.102, 1^st Floor, Aditya Trade Centre, Ameerpet, Hyderabad-500038, Andhra Pradesh
Country :	India
Financials (as on) :	31.03.2012
Date of Incorporation :	25.04.2000
Com. Reg. No.:	01 – 34319
Capital Investment / Paid-up Capital :	Rs.39.000 Millions
CIN No.: [Company Identification No.]	U24230AP2000PLC034319
TAN No.: [Tax Deduction & Collection Account No.]	HYDS03801A
Legal Form :	A Closely held Public Limited Liability Company
Line of Business :	Manufacturers of Active Pharmaceutical Ingredients (APIs) and Drug Intermediates
No. of Employees :	Not Available

RATING & COMMENTS

MIRA’s Rating :

Ba (43)

RATING		STATUS	PROPOSED CREDIT LINE
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory

Maximum Credit Limit :	USD 1000000
Status :	Satisfactory
Payment Behaviour :	Slow but correct
Litigation :	Exist
Comments :	Subject is a well established company having a satisfactory track record. Trade relations are reported as decent. Business is active. Payments are reported to be slow but correct. The company can be considered for business dealings at usual trade terms and conditions.

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

ECGC Country Risk Classification List – September 30, 2011

Country Name	Previous Rating (30.06.2011)	Current Rating (30.09.2011)
India	A1	A1

Risk Category	ECGC Classification
Insignificant	A1
Low	A2
Moderate	B1
High	B2
Very High	C1
Restricted	C2
Off-credit	D

EXTERNAL AGENCY RATING

Rating Agency Name	ICRA
Rating	Long term rating: BB+
Rating Explanation	Moderate risk of default
Date	January 2013

RBI DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

LOCATIONS

Registered Office :	Flat No.102, 1^st Floor, Aditya Trade Centre, Ameerpet, Hyderabad-500038, Andhra Pradesh, India
Tel. No.:	91-40-66361958 / 59
Fax No.:	91-40-23757626
E-Mail :	info@auctuspharma.com sales@auctuspharma.com finance@auctuspharma.com
Website :	http://www.auctuspharma.com
Factory 1:	154, Darga Road, Rangapur Village, Kothur Mandal, Mahaboobnagar-509228 District, Andhra Pradesh, India
Tel. No.:	91-8548-257278
Factory 2:	Plot No. 8, JN Pharma City, Tadi Village, Parawada Mandal, Visakhapatnam District, Andhra Pradesh, India
Factory 3:	# 216, Bonthapally Village, Jinnaram Mandal, Medak District, Andhra Pradesh, India
Tel. No.:	91-8458-275442

DIRECTORS

As on 08.08.2011

Name :

Mr. Aluru Sivarama Prasad

Designation :

Managing Director

Address :

Plot No.85, Siddhartha Nagar, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

10.01.1956

Date of Appointment :

03.11.2011

Din No.:

00361671

Other Directorship:

S. No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Company Status	Defaulting status
1	U24110AP1994PTC017884	NEO MEDICHEM PRIVATE LIMITED	Director	03-11-03	03-11-03	Amalgamated	NO
2	U24230AP2000PLC034319	AUCTUS PHARMA LIMITED	Managing director	03-11-11	03-11-03	Active	NO
3	U24100AP2010PLC066882	AUCTUS LIFE SCIENCES LIMITED	Director	02-02-10	02-02-10	Active	NO
4	U24232AP2011PTC072550	NVNS LABORATORIES PRIVATE LIMITED	Director	10-02-11	10-02-11	Active	NO

Name :

Mr. Suryadevara Venkateshwara Rao

Designation :

Managing Director

Address :

H No.8-2-293/8/2/NL/260, Road No. 10C, MLA and MPs Colony, Jubilee Hills, , Hyderabad – 500 033, Andhra Pradesh, India

Date of Birth/Age :

10.05.1964

Date of Appointment :

01.04.2011

Din No.:

00363121

Other Directorship:

S. No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Company Status	Defaulting status
1	U24110AP1994PTC017884	NEO MEDICHEM PRIVATE LIMITED	Managing director	09-12-02	09-12-02	Amalgamated	NO
2	U24230AP2000PLC034319	AUCTUS PHARMA LIMITED	Managing director	01-04-11	31-07-03	Active	NO
3	U24100AP2010PLC066882	AUCTUS LIFE SCIENCES LIMITED	Director	02-02-10	02-02-10	Active	NO
4	U24232AP2011PTC072550	NVNS LABORATORIES PRIVATE LIMITED	Director	10-02-11	10-02-11	Active	NO

Name :

Dr. Mohan Bandari

Designation :

Whole Time Director

Address :

Flat No.501, Sai Likhitas Samrat Sadan, 8-3-167/D/250 and 251, Kalyan Nagar, Phase I, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

15.04.1955

Date of Appointment :

04.04.2007

Din No.:

01422436

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U24230AP2000PLC034319	AUCTUS PHARMA LIMITED	Whole-time director	04/04/2012	04/04/2007	15/04/2013	Active	NO
2	U24100AP2010PLC066882	AUCTUS LIFE SCIENCES LIMITED	Director	02/02/2010	02/02/2010	18/05/2013	Active	NO

Name :

Talasila Venkateswara Rao

Designation :

Director

Address :

2-22-1/65/305, Dwaraka Mai Manson, Bhagya nagar Colony, Kukatpally, Hyderabad – 500 072, Andhra Pradesh, India

Date of Birth/Age :

09.04.1954

Date of Appointment :

16.06.2008

Din No.:

00686154

Other Directorship:

S. No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Company Status	Defaulting status
1	U24230AP1997PTC027928	INDU FORMULATIONS PRIVATE LIMITED	Managing director	11-09-97	11-09-97	Active	NO
2	U24230AP2000PLC034319	AUCTUS PHARMA LIMITED	Director	16-06-08	28-03-08	Active	NO

Name :

Kudaravalli Subramanyeswara Rao

Designation :

Director

Address :

7-1-636/26, Model Colony, S.R. Nagar, B.K. Guda, Hyderabad – 500 038, Andhra Pradesh, India

Date of Birth/Age :

10.08.1942

Date of Appointment :

16.06.2008

Din No.:

00038416

Other Directorship:

S.No.	CIN/LLPIN	Name of the Company/ LLP	Current designation of the Director/ Designated Partner	Date of appointment at current designation	Original date of appointment	Date of cessation	Company/ LLP Status	Defaulting status
1	U28932AP1975PLC006382	CMH TOOLS LIMITED	Director	14/03/2002	14/03/2002	-	Active	NO
2	L24239AP1987PLC008066	SMS PHARMACEUTICALS LIMITED	Director	29/05/2005	29/05/2005	-	Active	NO
3	U24230AP1995PTC020182	SREENIVASA PHARMA PRIVATE LIMITED	Director	25/05/2007	25/05/2007	-	Amalgamated	NO
4	U24230AP2000PLC034319	AUCTUS PHARMA LIMITED	Director	16/06/2008	28/03/2008	-	Active	NO
5	U45200AP2004PTC042471	YESWANTH INDUSTRIAL INFRASTRUTURE PROJECTS PRIVATE LIMITED (U/S 21)	Director	26/11/2011	26/11/2011	-	Active	NO
6	U31909AP1991PTC013404	THERMAL SYSTEMS (HYDERABAD)PRIVATE LIMITED	Director	29/09/2012	03/09/2012	-	Active	NO

Name :

Garlapati Nageswara Rao

Designation :

Director

Address :

H. No. 3-6-61/5/1, Plot NO. 374, Vivekananda Nagar, Kukatpally, Hyderabad-500072, Andhra Pradesh, India

Date of Birth/Age :

14.06.1962

Date of Appointment :

08.08.2011

Din No.:

01561484

Other Directorship:

S. No.	CIN	Name of the Company	Current designation of the director	Date of appointment at current designation	Original date of appointment	Company Status	Defaulting status
1	U25209AP1998PTC028831	VIJETHA POLYTEK PRIVATE LIMITED	Managing director	04-02-98	04-02-98	Active	NO
2	U24230AP2000PLC034319	AUCTUS PHARMA LIMITED	Director	08-08-11	14-09-10	Active	NO
3	U31900AP2011PTC074100	RAYDIANCE SOLAR ENERGY PRIVATE LIMITED	Director	26-04-11	26-04-11	Active	NO

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

As on 08.08.2011

Names of Shareholders	No. of Shares
Aluru Sivarama Prasad	1184000
Aluru Mahalakshmi	420500
Suryadevara Venkateshwara Rao	1286500
Suryadevara Lakshmidevi	382000
Mohan Bandari	150000
B. Sridhar	200000
Talasila Venkateswara Rao	25000
Talasila Hari Prasad	25000
Talasila Rajeswari	25000
Talasila Lakshmi Kumari	25000
Viljko Zorzut	50000
Bright Key Group Limited, Hong Kong	50000
Aluru Vasmsi Krishna	64000
Satambakkam Prem Kumar Reddy	6000
Dandu Ravi	3000
Parupalli Ramkumar	2000
Mullapudi Venkata Nagendra Rao	2000
Total	3900000

As on 08.08.2011

Equity Share Breakup	Percentage of Holding
Category
Foreign holdings [Foreign institutional investors, Foreign Companies, Foreign Financial Institutions, Non-resident Indian or Overseas corporate bodies or others]	2.56
Directors or relatives of directors	91.85
Other top fifty shareholders	5.59
Total	100.00

BUSINESS DETAILS

Line of Business :

Manufacturers of Active Pharmaceutical Ingredients (APIs) and Drug Intermediates

Products :

PRODUCT DESCRIPTION	ITEM CODE
Fluconazole	29036990
Citirizine	29242190
Pantoprazole	29332990
Losartanpostaslum	29153990

PRODUCTION STATUS [AS ON 31.03.2011]

Particulars	Unit	Installed Capacity	Actual Production
Bulk Drugs and Intermediates	Kgs.	400000	381037
Conversion	Kgs.	--	11816

GENERAL INFORMATION

No. of Employees :

Not Available

Bankers :

· Indian Overseas Bank, M.G. Road Branch, Chandralok Complex, Secunderabad-500003, Andhra Pradesh, India

· Indian Bank, Hyderabad Main Surabhi Arcade, Bank Street, Koti, Hyderabad-500001, Andhra Pradesh, India

Facilities :

Secured Loan	As on 31.03.2012 [Rs. in Millions]
Term loans from banks	49.030
Working capital loans from banks	163.929
Total	212.959

Secured Loan	As on 31.03.2011 [Rs. in Millions]
Term Loan
From Indian Bank [Payable within one year Rs.43.580 millions]	114.582
Working Capital Loan
From Indian Bank	91.566
Total	206.148

Banking Relations :	--
Auditors :
Name :	K. Nagaraju and Associates Chartered Accountants
Address :	H. No.1-8-197, Chikkadpally, Hyderabad – 500 020, Andhra Pradesh, India
Tel. No.:	91-40-27667878
Pan No.:	ABHPK1930B

CAPITAL STRUCTURE

As on 31.03.2012

Authorised Capital :

No. of Shares	Type	Value	Amount
4500000	Equity Shares	Rs.10/- each	Rs.45.000 Millions

Issued, Subscribed & Paid-up Capital :

No. of Shares	Type	Value	Amount
3900000	Equity Shares	Rs.10/- each	Rs.39.000 Millions

FINANCIAL DATA

[all figures are in Rupees Millions]

ABRIDGED BALANCE SHEET

SOURCES OF FUNDS		31.03.2012	31.03.2011	31.03.2010
SHAREHOLDERS FUNDS
1] Share Capital		39.000	39.000	37.000
2] Share Application Money		0.000	0.000	0.000
3] Reserves & Surplus		223.053	191.896	152.661
4] (Accumulated Losses)		0.000	0.000	0.000
NETWORTH		262.053	230.896	189.661
LOAN FUNDS
1] Secured Loans		212.959	206.148	174.241
2] Unsecured Loans		7.090	0.000	12.000
TOTAL BORROWING		220.049	206.148	186.241
DEFERRED TAX LIABILITIES		23.704	12.896	14.481
TOTAL		505.806	449.940	390.383
APPLICATION OF FUNDS
FIXED ASSETS [Net Block]		350.387	203.610	204.486
Capital work-in-progress		0.000	127.732	25.535
INVESTMENT		0.000	0.063	0.223
DEFERREX TAX ASSETS		0.000	0.000	0.000
CURRENT ASSETS, LOANS & ADVANCES
	Inventories	121.291	79.259	89.875
	Sundry Debtors	253.098	278.928	214.682
	Cash & Bank Balances	9.121	7.110	12.260
	Other Current Assets	0.906	1.081	0.890
	Loans & Advances	63.887	48.225	43.513
Total Current Assets		448.303	414.603	361.220
Less : CURRENT LIABILITIES & PROVISIONS
	Sundry Creditors	0.000	269.117	184.273
	Other Current Liabilities	286.958	12.500	0.000
	Provisions	5.926	14.451	16.808
Total Current Liabilities		292.884	296.068	201.081
Net Current Assets		155.419	118.535	160.139
MISCELLANEOUS EXPENSES		0.000	0.000	0.000
TOTAL		505.806	449.940	390.383

PROFIT & LOSS ACCOUNT

	PARTICULARS		31.03.2012	31.03.2011	31.03.2010
	SALES
		Income	963.051	945.117	759.610
		Other Income	17.131	4.219	3.503
		TOTAL (A)	980.182	949.336	763.113
Less	EXPENSES
		Material Consumed	757.713	664.533	550.953
		Manufacturing Expenses	--	78.899	66.201
		Employee Cost	51.358	56.612	47.714
		Administrative Expenses	--	13.762	15.507
		Selling Expenses	--	18.345	15.831
		Increase / Decrease in Stocks	(28.349)	13.673	(18.281)
		Other expenses	123.775	--	--
		Extraordinary items	(36.791)	--	--
		TOTAL (B)	867.706	845.824	677.925
Less	PROFIT / (LOSS) BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION (A-B) (C)		112.476	103.512	85.188
Less	FINANCIAL EXPENSES (D)		29.338	21.800	19.855
	PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION (C-D) (E)		83.138	81.712	65.333
Less/ Add	DEPRECIATION/ AMORTISATION (F)		33.862	24.657	24.007
	PROFIT / (LOSS) BEFORE TAX (E-F) (G)		49.276	57.055	41.326
Less	TAX (H)		15.399	19.349	15.108
	PROFIT / (LOSS) AFTER TAX (G-H) (I)		33.877	37.706	26.218
Add	PREVIOUS YEARS’ BALANCE BROUGHT FORWARD		4.395	3.161	2.073
Less	APPROPRIATIONS
		Interim Dividend	NA	5.550	0.000
		Proposed Dividend	NA	0.000	4.399
		Tax on Dividend	NA	0.922	0.731
		Transfer to General Reserve	NA	30.000	20.000
	BALANCE CARRIED TO THE B/S		NA	4.395	3.161
	EARNINGS IN FOREIGN CURRENCY
		Export Earnings	NA	290.212	353.732
	IMPORTS
		Raw Materials	NA	131.105	145.138
		Capital Goods	NA	1.767	0.977
	TOTAL IMPORTS		NA	132.872	146.115
	Earnings / (Loss) Per Share (Rs.) (Basic)		8.69	9.67	7.09
	Earnings / (Loss) Per Share (Rs.) (Diluted)		8.69	9.20	7.02

KEY RATIOS

PARTICULARS		31.03.2012	31.03.2011	31.03.2010
PAT / Total Income	(%)	3.46	3.97	3.44
Net Profit Margin (PBT/Sales)	(%)	5.12	6.04	5.44
Return on Total Assets (PBT/Total Assets}	(%)	10.99	9.23	7.31
Return on Investment (ROI) (PBT/Networth)		0.19	0.25	0.22
Debt Equity Ratio (Total Debt /Networth)		0.95	0.89	0.98
Current Ratio (Current Asset/Current Liability)		1.53	1.40	1.80

LOCAL AGENCY FURTHER INFORMATION

Sr. No.	Check List by Info Agents	Available in Report (Yes / No)
1]	Year of Establishment	Yes
2]	Locality of the firm	Yes
3]	Constitutions of the firm	Yes
4]	Premises details	No
5]	Type of Business	Yes
6]	Line of Business	Yes
7]	Promoter's background	Yes
8]	No. of employees	No
9]	Name of person contacted	No
10]	Designation of contact person	No
11]	Turnover of firm for last three years	Yes
12]	Profitability for last three years	Yes
13]	Reasons for variation <> 20%	--
14]	Estimation for coming financial year	No
15]	Capital in the business	Yes
16]	Details of sister concerns	No
17]	Major suppliers	No
18]	Major customers	No
19]	Payments terms	No
20]	Export / Import details (if applicable)	No
21]	Market information	--
22]	Litigations that the firm / promoter involved in	Yes
23]	Banking Details	Yes
24]	Banking facility details	Yes
25]	Conduct of the banking account	--
26]	Buyer visit details	--
27]	Financials, if provided	Yes
28]	Incorporation details, if applicable	Yes
29]	Last accounts filed at ROC	Yes
30]	Major Shareholders, if available	Yes
31]	Date of Birth of Proprietor/Partner/Director, if available	Yes
32]	PAN of Proprietor/Partner/Director, if available	No
33]	Voter ID No of Proprietor/Partner/Director, if available	No
34]	External Agency Rating, if available	Yes

LITIGATION DETAILS

ITTA 204 / 2011

ITTASR 3359 / 2008

CASE IS:PENDING

PETITIONER		RESPONDENT
THE COMMISSIONER OF INCOME TAX-I, HYDERABAD	VS	M/S. AUCTUS PHARMA PRIVATE LIMITED
PET.ADV. : PRASAD (SC FOR INCOME TAX)		RESP.ADV. : RAMASWAMI
SUBJECT: U/Sec. 143 Assessment		DISTRICT:  HYDERABAD

FILING DATE:  15-11-2008	POSTING STAGE :  FINAL HEARING
REG. DATE    :   26-05-2011	LISTING DATE :  03-06-2013	STATUS   :  ---------

HON'BLE JUDGE(S):

G.ROHINI

P NAVEEN RAO

UNSECURED LOAN

PARTICULARS	31.03.2012 (Rs. in Millions)
Term loans from banks	7.090
Total	7.090

UNSECURED LOAN	31.03.2011 (Rs. in Millions)
From Directors	0.000
Total	0.000

BANKERS CHARGES REPORT AS PER REGISTRY

Corporate identity number of the company	U24230AP2000PLC034319
Name of the company	AUCTUS PHARMA LIMITED
Address of the registered office or of the principal place of business in India of the company	Flat No.102, 1^st Floor, Aditya Trade Centre, Ameerpet, Hyderabad-500038, Andhra Pradesh, India Email: finance@auctuspharma.com
This form is for	Modification of charge
Charge identification (ID) number of the charge to be modified	10009990
Type of charge	· Immovable property · Book debts · Movable property (not being pledge) · Extension of Eq Mortgage on company's properties
Particular of charge holder	(CIN: U24230AP2000PLC034319) Indian Bank, Hyderabad Main Surabhi Arcade, Bank Street, Koti, Hyderabad-500001, Andhra Pradesh, India Email: ibhydmain@rediffmail.com
Nature of instrument creating charge	1. Sanction Letter 2. MTL Agreement 3. Agreement for OCC (Stocks/Book Debts) 4. Agreement for Increase in Cash Credit Limit. 5. Agreement for extension of hypothecation/pledge of movables. 6. Agreement for PC.7. Agreement of Guarantee. 8. Agreement for Bills Purchased. 9. Agreement of Pledge of Goods/Documents of Title to Goods.
Date of instrument Creating the charge	20.11.2012
Amount secured by the charge	Rs.410.700 Millions
Brief of the principal terms an conditions and extent and operation of the charge	Rate of Interest OCC BR+TP+Spread 2.75% PC:BR+2%. FBP/FBN:BPLR +2%, MTLIV: BPLR+TP-1.5%.MTLV:BPLR+TP-1% MTLVI BR+TP+2.75%.INL/IMP LC: 60% of Bank commission. Guarantee: commission as per Bank rules. Terms of Repayment Working capital limits are repayable on demand. MTL I to MTL III closed. There is no change in repayment schedule for MTL IV to V. MTL VI repayable in 20 quarterly installments of Rs. 2.000 Millions, commencing 12 months after date of 1st disbursement. Margin 25% on MTL, 25% on OCC, 10% ON FBP/FBN, Inland/Import LC/DA/DP and performance Guarantee. Extent and Operation of the charge 1. Exclusive First Charge on Company's Fixed Assets. 2. Hypothecation of stocks and book debts. Others 2THS
Short particulars of the property or asset(s) charged (including complete address and location of the property)	Extension of EM of Ac 6.00 situated in plot no. 8, under survey no's part of 156, 157, 159, 160 and 161 of Tadi Village of Parawada Mandal, Visakhapatnam district. EM of factory land, building, P and M, in situated at SY No. 216, Bonthapalli Village, Jinnaram Mandal, Medak District belonging to company. EM of Office premises admeasuring 2691 sft on 7th Floor, Aditya Trade Centre, Ameerpet, Hyderabad,belonging to Mr. S. V. Rao, and Mrs. Lakshmi Devi. Shop No. 13, Annapurna Block, Aditya Enclave, Ameerpet, Hyderabad,belonging to Shri A. Siva Rama Prasad,
Date of instrument modifying the charge	01.03.2011
Particulars of the present modification	Total fund based and non fund based limits were reduced from Rs. 474.400 Millions to Rs.410.700 Millions

FIXED ASSETS:

· Land

· Building

· Plant and Machinery

· Pipes and Valves

· Electrical Installation

· Lab Equipment

· Factory Equipment

· Computers

· Furniture and Fixtures

· Vehicles

· Office Equipment

CMT REPORT (Corruption, Money Laundering & Terrorism]

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

1] INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

2] Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

3] Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

4] Record on Financial Crime :

Charges or conviction registered against subject: None

5] Records on Violation of Anti-Corruption Laws :

Charges or investigation registered against subject: None

6] Records on Int’l Anti-Money Laundering Laws/Standards :

Charges or investigation registered against subject: None

7] Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

8] Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

9] Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

10] Press Report :

No press reports / filings exists on the subject.

CORPORATE GOVERNANCE

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

CONTRAVENTION

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

FOREIGN EXCHANGE RATES

Currency	Unit	Indian Rupees
US Dollar	1	Rs.56.50
UK Pound	1	Rs.86.01
Euro	1	Rs.73.68

INFORMATION DETAILS

Report Prepared by :

KVT

SCORE & RATING EXPLANATIONS

SCORE FACTORS	RANGE	POINTS
HISTORY	1~10	4
PAID-UP CAPITAL	1~10	4
OPERATING SCALE	1~10	6
FINANCIAL CONDITION
--BUSINESS SCALE	1~10	6
--PROFITABILIRY	1~10	5
--LIQUIDITY	1~10	4
--LEVERAGE	1~10	4
--RESERVES	1~10	5
--CREDIT LINES	1~10	5
--MARGINS	-5~5	-
DEMERIT POINTS
--BANK CHARGES	YES/NO	YES
--LITIGATION	YES/NO	YES
--OTHER ADVERSE INFORMATION	YES/NO	NO
MERIT POINTS
--SOLE DISTRIBUTORSHIP	YES/NO	NO
--EXPORT ACTIVITIES	YES/NO	NO
--AFFILIATION	YES/NO	NO
--LISTED	YES/NO	NO
--OTHER MERIT FACTORS	YES/NO	YES
DEFAULTER
--RBI	YES/NO	NO
--EPF	YES/NO	NO
TOTAL		43

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

Financial condition (40%) Ownership background (20%) Payment record (10%)

Credit history (10%) Market trend (10%) Operational size (10%)

RATING EXPLANATIONS

RATING		STATUS	PROPOSED CREDIT LINE
>86	Aaa	Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums	Unlimited
71-85	Aa	Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums	Large
56-70	A	Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums	Fairly Large
41-55	Ba	Overall operation is considered normal. Capable to meet normal commitments.	Satisfactory
26-40	B	Capability to overcome financial difficulties seems comparatively below average.	Small
11-25	Ca	Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity	Limited with full security
<10	C	Absolute credit risk exists. Caution needed to be exercised	Credit not recommended
-	NB	New Business	-

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.